Seasonal Variation in Relapse Rate of Graves' Disease after Thionamide Drug Treatment

Endocrine Journal

Volumn 50, Issue 6, 2003, Pages 669-672

  Misaki, Takashi ^a,b   Iida, Yasuhiro ^a   Kasagi, Kanji ^a,c   Konishi, Junji ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TENRI HOSPITAL   (Japan)

^c TAKAMATSU RED CROSS HOSPITAL   (Japan)

Author keywords

Antithyroid drug; Environmental factor; Graves' disease; TSH receptor antibodies

Indexed keywords

ANTITHYROID AGENT; IMMUNOGLOBULIN; THIONAMIDE; THYROTROPIN;

ADULT; ARTICLE; AUTUMN; DISEASE ACTIVITY; DISEASE EXACERBATION; FEMALE; FOLLOW UP; GRAVES DISEASE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; RELAPSE; RETROSPECTIVE STUDY; SEASONAL VARIATION; SPRING; SUMMER; SYMPTOMATOLOGY; THYROTROPIN BLOOD LEVEL; TREATMENT OUTCOME; WINTER;

ADULT; ANTITHYROID AGENTS; AUTOANTIBODIES; FEMALE; GRAVES DISEASE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RECEPTORS, THYROTROPIN; RECURRENCE; RETROSPECTIVE STUDIES; SEASONS;

EID: 0942287792     PISSN: 09188959     EISSN: None     Source Type: Journal    
DOI: 10.1507/endocrj.50.669     Document Type: Article

References (18)

1. Smith BR, McLachlan SM, Furmaniac J (1988) Autoantibodies to the thyrotropin receptor. Endocr Rev 9: 106-121.
2. Weetman AP (1997) New aspects of thyroid immunity. Horm Res 48 (suppl. 4): 51-54.
3. Farid NR, Stone E, Johnson G (1980) Graves' disease and HLA: clinical and epidemiological associations. Clin Endocrinol 13: 535-544.
4. Inoue D, Sato K, Enomoto T, Sugawa H, Maeda M, Inoko H, Tsuji K, Mori T, Imura H (1992) Correlation of HLA types and clinical findings in Japanese patients with hyperthyroid Graves' disease: evidence indicating the existence of four subpopulations. Clin Endocrinol 36: 75-82.
5. Kung AWC (1995) Life events, daily stresses and coping in patients with Graves' disease. Clin Endocrinol 42: 303-308.
6. Matos-Santos A, Nobre EL, Costa JGE, Nogueira PJ, Macedo A, Galvaõ-Teles A, de Castro JJ (2001) Relationship between the number and impact of stressful life events and the onset of Graves' disease and toxic nodular goiter. Clin Endocrinol 55: 15-19.
7. Dayan CM (2001) Stressful life events and Graves' disease revisited. Clin Endocrinol 55: 13-14.
8. Westphal SA (1994) Seasonal variation in the diagnosis of Graves' disease. Clin Endocrinol 41: 27-30.
9. Buchinger W, Semlitsch G, Pongratz R, Harwalik B, Rainer F (2000) Jahreszeitliche Variationen im Auftreten der Hyperthyreose. Acta Med Austriaca 27: 51-53.
10. Brownlie BE, Wells JE (1990) The epidemiology of thyrotoxicosis in New Zealand: incidence and geographical distribution in north Canterbury, 1983-1985. Clin Endocrinol 33: 249-259.
11. Facciani JM, Kazim M (2000) Absence of seasonal variation in Graves disease. Ophthal Plast Reconstr Surg 16: 67-71.
12. Misaki T, Miyamoto S, Kasagi K, Mori T, Konishi J (1996) Serial occurrence of two types of postpartum thyroid disorders: usefulness of Tc-99 m pertechnetate uptake. Clin Nucl Med 21: 460-462.
13. Southgate K, Creagh F, Teece M, Kingswood C, Smith BR (1984) A receptor assay for the measurement of TSH receptor antibodies in unextracted serum. Clin Endocrinol 20: 539-543.
14. Konishi J, Kasagi K, Iida Y, Kousaka T, Misaki T, Arai K, Tokuda Y, Torizuka K (1987) Optimization and clinical assessment of a radioreceptor assay for thyrotropin-binding inhibitor immunoglobulins. Endocrinol Japon 34: 13-20.
15. Costagliola S, Morgenthaler NG, Hoermann R, Badenhoop K, Struck J, Freitag D, Poertl S, Weglöhner W, Hollidt JM, Quadbeck B, Dumont JE, Schumm-Draeger P-M, Bergmann A, Mann K, Vassart G, Usadel K-H (1999) Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves' disease. J Clin Endocrinol Metab 84: 90-97.
16. Kashiwai T, Hidaka Y, Takano T, Tatsumi K, Izumi Y, Shimaoka Y, Tada H, Takeoka K, Amino N (2003) Practical treatment with minimum maintenance dose of antithyroid drugs for prediction of remission in Graves' disease. Endocr J 50: 45-49.
17. Hidaka Y, Amino N, Iwatani Y, Itoh E, Matsunaga M, Tamaki H (1993) Recurrence of thyrotoxicosis after attack of allergic rhinitis in patients with Graves' disease. J Clin Endocrionol Metab 77: 1667-1670.
18. Kasagi K, lida Y, Hatabu H, Tokuda Y, Arai K, Endo K, Konishi J (1988) Evaluation of TSH-receptor antibodies as prognostic markers after cessation of antithyroid drug treatment in patients with Graves' disease. Acta Endocrinol 117: 173-180.